Resource Library
Showing 1 to 10 of 328 results
Image
Burkitt leukemia is a rare and highly aggressive blood cancer closely related to Burkitt lymphoma. It develops when abnormal B cells are found primarily in the bone marrow and blood. Burkitt leukemia most often affects children and young adults and requires prompt treatment, but many people can achieve remission and be cured.
Image
Acute lymphoblastic leukemia (ALL) affects immature white blood cells called lymphoblasts and can progresses quickly without treatment. Dr. Dawn Maze, a member of the Leukemia Program and the Elizabeth and Tony Comper MPN Program at the Princess Margaret Cancer Centre, addresses treatment of acute lymphoblastic leukemia, advances in research and management…
Image
Dr. Vikas Gupta, Hematologist at the Princess Margaret Cancer Centre in Toronto, reviewed Myelofibrosis (MF) and the evolution in diagnosis, treatment options and aspects of follow-up care in this 1-hour webcast as part of MPN Conference 2025.
Image
In this 1-hour webcast, Dr. Lynda Foltz, University of British Columbia, will review this type of myeloproliferative neoplasm (MPN): its diagnosis, treatment options, and aspects of follow-up care.) People with ET have too many platelets, a type of blood cell. Too many platelets can result in a blood clot (thrombosis) forming in a blood vessel.
Image
This animated video is designed to help children and their parents understand what chemotherapy is and what to expect if it is part of their blood cancer treatment.
Image
In this 60-minute virtual webcast, Dr Jacqueline Costello will explain key concepts in clear, accessible language and share how advances in targeted therapies and newer treatments are expanding options and shaping care. You’ll gain insight into how treatment approaches are selected, what new developments may mean and how to better understand the choices…
Image
Learn about Hodgkin lymphoma treatment, life after treatment, and future health considerations in this informative session presented by lymphoma specialist Dr. Michael Crump.
Image
Chronic myeloid leukemia (CML) is a rare type of leukemia that can happen when cells that make the blood develop a genetic change called BCR-ABL1 (Philadelphia chromone). Dr. M. Lynn Savoie, hematologist at Tom Baker Cancer Centre in Calgary, Alberta, discusses treatment options, including hematopoiesis stem cell transplants, and ways to minimize side…
Image
Learn more about CML treatment option and side effects.